Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CELC |
---|---|---|
09:32 ET | 1974 | 16.38 |
09:34 ET | 5449 | 16.2001 |
09:36 ET | 100 | 16.225 |
09:45 ET | 488 | 16.33 |
09:50 ET | 500 | 16.22 |
09:52 ET | 300 | 16.26 |
09:59 ET | 500 | 16.37 |
10:01 ET | 882 | 16.49 |
10:03 ET | 100 | 16.39 |
10:06 ET | 100 | 16.3587 |
10:08 ET | 100 | 16.37 |
10:12 ET | 1174 | 16.225 |
10:14 ET | 100 | 16.215 |
10:15 ET | 200 | 16.215 |
10:17 ET | 138 | 16.2981 |
10:19 ET | 1900 | 16.315 |
10:32 ET | 507 | 16.32 |
10:37 ET | 444 | 16.32 |
10:42 ET | 1100 | 16.24 |
10:44 ET | 2200 | 16.24 |
10:46 ET | 100 | 16.225 |
10:50 ET | 102 | 16.2125 |
10:51 ET | 300 | 16.27 |
10:53 ET | 300 | 16.21 |
10:55 ET | 206 | 16.1875 |
10:57 ET | 600 | 16.225 |
11:02 ET | 200 | 16.23 |
11:04 ET | 900 | 16.26 |
11:09 ET | 100 | 16.265 |
11:11 ET | 200 | 16.265 |
11:15 ET | 900 | 16.225 |
11:18 ET | 325 | 16.245 |
11:20 ET | 400 | 16.21 |
11:26 ET | 300 | 16.25 |
11:27 ET | 1100 | 16.25 |
11:29 ET | 204 | 16.23 |
11:33 ET | 1003 | 16.22 |
11:36 ET | 775 | 16.21 |
11:38 ET | 975 | 16.21 |
11:40 ET | 526 | 16.23 |
11:42 ET | 1327 | 16.21 |
11:44 ET | 304 | 16.21 |
11:45 ET | 3653 | 16.345 |
11:51 ET | 512 | 16.345 |
11:54 ET | 104 | 16.345 |
11:56 ET | 200 | 16.305 |
11:58 ET | 100 | 16.28 |
12:02 ET | 100 | 16.295 |
12:07 ET | 930 | 16.345 |
12:14 ET | 1545 | 16.435 |
12:16 ET | 100 | 16.39 |
12:20 ET | 285 | 16.38 |
12:21 ET | 422 | 16.39 |
12:27 ET | 300 | 16.41 |
12:32 ET | 100 | 16.44 |
12:34 ET | 200 | 16.48 |
12:38 ET | 200 | 16.48 |
12:41 ET | 100 | 16.4766 |
12:48 ET | 300 | 16.52 |
12:50 ET | 1025 | 16.565 |
12:54 ET | 200 | 16.6 |
12:56 ET | 700 | 16.61 |
12:57 ET | 200 | 16.65 |
01:01 ET | 150 | 16.6 |
01:03 ET | 600 | 16.59 |
01:12 ET | 200 | 16.59 |
01:14 ET | 700 | 16.62 |
01:15 ET | 690 | 16.62 |
01:19 ET | 109 | 16.62 |
01:21 ET | 615 | 16.68 |
01:26 ET | 100 | 16.66 |
01:28 ET | 350 | 16.665 |
01:32 ET | 100 | 16.69 |
01:35 ET | 400 | 16.69 |
01:37 ET | 100 | 16.68 |
01:39 ET | 400 | 16.665 |
01:46 ET | 100 | 16.66 |
01:48 ET | 1404 | 16.6 |
01:50 ET | 250 | 16.55 |
02:04 ET | 802 | 16.6 |
02:11 ET | 100 | 16.62 |
02:15 ET | 200 | 16.645 |
02:24 ET | 100 | 16.68 |
02:26 ET | 100 | 16.68 |
02:29 ET | 300 | 16.67 |
02:33 ET | 100 | 16.68 |
02:36 ET | 100 | 16.67 |
02:38 ET | 495 | 16.66 |
02:45 ET | 100 | 16.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Celcuity Inc | 575.0M | -6.0x | --- |
Humacyte Inc | 571.6M | -5.2x | --- |
Mineralys Therapeutics Inc | 580.9M | -5.5x | --- |
Erasca Inc | 561.6M | -2.9x | --- |
Cassava Sciences Inc | 592.5M | -10.7x | --- |
Savara Inc | 556.9M | -12.2x | --- |
Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small molecule reversible inhibitor, that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic target of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its initial clinical development programs for gedatolisib are focusing on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. Its VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells to identify new groups of cancer patients.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $575.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $-2.79 |
Book Value | $5.48 |
P/E Ratio | -6.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.